TWST Live signals | Maximize Profits with Getagraph.com

SELL 137573 min ago

@ $41.45

Issued: 28 Feb 2024 @ 11:54

Return: 1.09%

Previous signal: Feb 27 - 15:51

Previous signal: Buy

Return: 0.70 %

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Stats
Today's Volume	1.34M
Average Volume	951 257
Market Cap	2.44B
EPS	$0 ( 2024-05-03 )
Next earnings date	( $-0.790 ) 2024-08-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-12.47
ATR14	$0.0780 (0.19%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-23	Werner Robert F.	Sell	3 361	Common Stock
2024-05-03	Banyai William	Sell	798	Common Stock
2024-05-03	Cho Dennis	Sell	568	Common Stock
2024-05-03	Green Paula	Sell	910	Common Stock
2024-05-03	Leproust Emily M.	Sell	4 163	Common Stock

INSIDER POWER
73.08
Last 100 transactions
Buy: 618 828 \| Sell: 88 321

Volume Correlation

Long: 0.04 (neutral)

Short: -0.27 (neutral)

Signal:(59.045) Neutral

Twist Bioscience Corp Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Twist Bioscience Corp Correlation - Currency/Commodity

0.56
( weak )

0.49
( neutral )

0.00
( neutral )

0.59
( weak )

-0.49
( neutral )

Twist Bioscience Corp Financials

Annual	2023
Revenue:	$245.11M
Gross Profit:	$89.73M (36.61 %)
EPS:	$-3.60

FY	2023
Revenue:	$245.11M
Gross Profit:	$89.73M (36.61 %)
EPS:	$-3.60

FY	2022
Revenue:	$203.57M
Gross Profit:	$84.24M (41.38 %)
EPS:	$-4.04

FY	2021
Revenue:	$132.33M
Gross Profit:	$51.71M (39.08 %)
EPS:	$-3.15

Financial Reports:

No articles found.

Twist Bioscience Corp Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Twist Bioscience Corp

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.